Ballentine Partners’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-252
Closed -$17K 746
2023
Q4
$17K Sell
252
-50
-17% -$3.38K ﹤0.01% 680
2023
Q3
$21.9K Buy
+302
New +$21.9K ﹤0.01% 600
2023
Q2
Sell
-263
Closed -$14K 609
2023
Q1
$14K Sell
263
-302
-53% -$16.1K ﹤0.01% 567
2022
Q4
$38.2K Buy
+565
New +$38.2K ﹤0.01% 506